skip to content »

Roche non sedating anxiety antidepressant

roche non sedating anxiety antidepressant-35

Some of the reported cases of serotonin syndrome were fatal.

roche non sedating anxiety antidepressant-7roche non sedating anxiety antidepressant-31roche non sedating anxiety antidepressant-44roche non sedating anxiety antidepressant-53

Activase is supplied directly to hospitals and used in a hospital setting.A missed dose of midazolam may lead to ineffective sedation and/or anxiety related to patient recall of a surgical or diagnostic procedure.If a selection error occurs, a patient who may have received a pre-operative dose of ondansetron may inadvertently receive an additional dose of ondansetron.Each 100 mg Activase vial (58 million IU) is packaged with diluent for reconstitution (100 m L Sterile Water for Injection, USP), and one transfer device: NDC 50242-085-27.The product was distributed nationwide to hospitals.Customers that have any of the affected medications that are being recalled should immediately quarantine the product, discontinue use and destroy per their hospital protocol.

Customers with any of the affected medications can also reference Phar MEDium Services website for more information on the specific lot numbers affected and contact information:

These products were distributed nationwide in the USA to hospitals/clinics.

Phar MEDium Services is notifying customers of the voluntary recall by phone.

Serotonin syndrome is associated with increased serotonergic activity in the central nervous system.

Most reports of serotonin syndrome have been associated with concomitant use of certain drugs, some commonly used during surgery, such as fenta NYL.

Consumers with questions regarding this recall can contact Fresenius Kabi Quality Assurance at 1-866-716-2459.